Moderator: Frederick J. Schoen, MD, PhD, Professor of Pathology and Health Sciences and Technology, Harvard Medical School; Director of Cardiac Pathology and Executive Vice-Chairman, Department of Pathology, Brigham and Women's Hospital; Director, BWH Biomedical Research Institute (BRI) Technology in Medicine Initiative; CIMIT Site Miner, BWH, fschoen@partners.org
The X-Prize Model for Stimulating Solutions to Grand Medical Challenges
Erika Wagner,
PhD, Founding Executive Director, X PRIZE Lab @ MIT, erika@MIT.EDU
In 2004 the Ansari X PRIZE for suborbital spaceflight captured the
public's imagination, leveraging a $10M prize purse into over $100M in
innovation. Now the X PRIZE Foundation is developing new prizes to focus
on innovation around other "Grand
Challenge" themes, including a
number related to health and healthcare. Unlike traditional awards that
only recognize success in hindsight, these incentive prizes challenge
the best minds, whoever and wherever they may be, to rise to a well-defined
challenge. These prizes use the powerful incentive of competition on
a global stage to generate incredible leverage for the grantor and they
only pay out on success. In inefficient markets and landscapes where
the best road to a solution is unclear, prizes offer a valuable alternative
to traditional grants and venture funding.
The New Harvard Clinical and Translational Science Award (CTSA): Opportunities and Challenges
Gordon H. Williams,
MD, Professor of Medicine, Harvard Medical School; Senior Physician,
Brigham and Women’s Hospital, gwilliams@partners.org
The Harvard Catalyst Participant and Clinical Interaction Resources (PCIR) program allows investigators to perform cutting edge human research and facilitates human interdisciplinary research across the broad spectrum of departments and research areas through transformation and extension of the prior NIH-funded General Clinical Research Centers. Now referred to as Harvard-wide Human Research Laboratories (HRL), this resource incorporates dedicated in and out patient clinical research sites, clinical research personnel and core laboratory services at the following participating Institutions: Beth Israel-Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Massachusetts General Hospital and Massachusetts Institute of Technology. Each provides resources available to assist investigators throughout within as well as across these Institutions. Selected resources are available both within space dedicated to the HRLs and in the near future off-site in other areas where patients are located such as the intensive care units and the emergency departments.
Comments